Target intelligence / Profile preview

T cell receptor beta variable 10-3 (TRBV10-3)

Target
TRBV10-3
Molecular classification
Receptor, Cell surface receptor, Immunoglobulin superfamily, Non-catalytic tyrosine-phosphorylated receptor (NTR)[2]
01

Overview

T cell receptor beta variable 10-3 (TRBV10-3) is a protein segment that forms part of the variable domain of the T cell receptor (TCR) beta chain, which is expressed on the surface of T lymphocytes. TRBV10-3 participates in the adaptive immune response by enabling T cells to recognize antigenic peptides presented by major histocompatibility complex (MHC) molecules on antigen-presenting cells. The TCR, consisting of alpha and beta chains, initiates signaling cascades that lead to T cell activation and immune function. TRBV10-3 is one of many variable regions generated through somatic recombination, contributing to the enormous diversity of antigen recognition by T cells. It is not itself a druggable target but plays a fundamental role in immune surveillance and can be involved in immune monitoring, immunotherapy, and disease pathogenesis when certain T cell clones expand abnormally[1][2][4][7][8].

Other names
TCRBV10S3TCRBV12S1A1N2TRBV103V segment translation productTCRBV10-3[1][5][8]
02

Mechanism of action

Adoptive transfer of T cells engineered to express TCRs; Redirection of T cell specificity for therapeutic immune responses; Immunotherapy targeting TCR variants (in general, not specific to TRBV10-3)[6]

03

Biological functions

Antigen recognitionImmune responseSignal transductionRepertoire diversity generation through V-(D)-J recombination[1][2][4][8]
04

Disease associations

InfectionCancerImmune-mediated diseasesOther (immunodeficiency, graft-versus-host disease, autoimmune disorders, etc.)[1][4][6]
05

Safety considerations

Potential for autoimmunity if engineered TCRs recognize self-peptidesOff-target immune responsesImmunogenicity of engineered T cellsGraft-versus-host disease in allogeneic contexts[6]
06

Biomarkers

TCR variable region usage as a biomarker for clonal T-cell populationsImmune repertoire diversity for monitoring immune status or minimal residual disease (general to TCR V segments, including TRBV10-3)[4]

Beyond the preview

Go deeper on T cell receptor beta variable 10-3 (TRBV10-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on T cell receptor beta variable 10-3 (TRBV10-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call